SI0717043T1 - Use of 1,2-bridged 1,4-dihydropyridines as selective potassium channel modulators - Google Patents

Use of 1,2-bridged 1,4-dihydropyridines as selective potassium channel modulators

Info

Publication number
SI0717043T1
SI0717043T1 SI9530352T SI9530352T SI0717043T1 SI 0717043 T1 SI0717043 T1 SI 0717043T1 SI 9530352 T SI9530352 T SI 9530352T SI 9530352 T SI9530352 T SI 9530352T SI 0717043 T1 SI0717043 T1 SI 0717043T1
Authority
SI
Slovenia
Prior art keywords
dihydropyridines
bridged
potassium channel
channel modulators
selective potassium
Prior art date
Application number
SI9530352T
Other languages
English (en)
Slovenian (sl)
Inventor
Klaus Dr. Urbahns
Hans-Georg Dr. Heine
Bodo Dr. Junge
Thomas Dr. Glaser
Reilinde Wittka
Vry Jean-Marie-Viktor Dr. De
Henning Dr. Sommermeyer
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SI0717043T1 publication Critical patent/SI0717043T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
SI9530352T 1994-12-16 1995-12-04 Use of 1,2-bridged 1,4-dihydropyridines as selective potassium channel modulators SI0717043T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4444860A DE4444860A1 (de) 1994-12-16 1994-12-16 Verwendung von 1,2-überbrückten 1,4-Dihydropyridinen als Arzneimittel
EP95119052A EP0717043B1 (de) 1994-12-16 1995-12-04 Verwendung von 1,2-überbrückten 1,4-Dihydropyridinen als selektive Kaliumkanalmodulatoren

Publications (1)

Publication Number Publication Date
SI0717043T1 true SI0717043T1 (en) 2000-02-29

Family

ID=6535985

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9530352T SI0717043T1 (en) 1994-12-16 1995-12-04 Use of 1,2-bridged 1,4-dihydropyridines as selective potassium channel modulators

Country Status (25)

Country Link
US (2) US5990121A (no)
EP (2) EP0924211A3 (no)
JP (1) JPH08239384A (no)
KR (1) KR960022517A (no)
CN (1) CN1059442C (no)
AT (1) ATE186536T1 (no)
AU (1) AU709760B2 (no)
CA (1) CA2165131A1 (no)
CZ (1) CZ332895A3 (no)
DE (2) DE4444860A1 (no)
DK (1) DK0717043T3 (no)
EE (1) EE9500076A (no)
ES (1) ES2139824T3 (no)
FI (1) FI956016A (no)
GR (1) GR3032394T3 (no)
HU (1) HUT74166A (no)
IL (1) IL116386A (no)
MX (1) MX9505097A (no)
NO (1) NO955103L (no)
NZ (1) NZ280661A (no)
PL (1) PL180439B1 (no)
RU (1) RU2155765C2 (no)
SI (1) SI0717043T1 (no)
SK (1) SK158095A3 (no)
ZA (1) ZA9510695B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050075359A1 (en) * 2003-03-14 2005-04-07 Rikako Kono Large conductance calcium-activated K channel opener
US7394475B2 (en) * 2004-02-13 2008-07-01 Infoprint Solutions Company, Llc Apparatus, system, and method for image registration
JP2008503548A (ja) * 2004-06-23 2008-02-07 ニューロテック、ファルマ、ソシエダッド、リミターダ 中枢神経系の炎症の治療のための化合物
CA2571718A1 (en) * 2004-06-23 2006-01-05 Josette-Nicole Mahy Gehenne Compounds for the treatment of an acute injury to the central nervous system
AU2006203819A1 (en) * 2005-01-07 2006-07-13 Roskamp Research Llc Compounds for inhibiting beta-amyloid production and methods of identifying the compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE220633C (no) *
US3951988A (en) * 1972-03-06 1976-04-20 Bayer Aktiengesellschaft 1,2-Pentamethylene-1,4-dihydropyridine derivatives
DE2210674C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2-Amino-6-methyl-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
US3935220A (en) * 1972-03-06 1976-01-27 Bayer Aktiengesellschaft Tetrahydroimidazolo[1,2-a]pyridine derivatives
DE2210633C2 (de) * 1972-03-06 1983-09-22 Bayer Ag, 5090 Leverkusen Kondensierte Pyridinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4053614A (en) * 1972-03-06 1977-10-11 Bayer Aktiengesellschaft 1,2-pentamethylene-1,4-dihydropyridine derivatives
US5225566A (en) * 1992-05-08 1993-07-06 American Home Products Corporation Indazolanonyl derivative of benzopyran

Also Published As

Publication number Publication date
SK158095A3 (en) 1996-09-04
JPH08239384A (ja) 1996-09-17
EP0924211A3 (de) 1999-07-07
CZ332895A3 (en) 1997-12-17
CA2165131A1 (en) 1996-06-17
IL116386A0 (en) 1996-03-31
EP0717043B1 (de) 1999-11-10
RU2155765C2 (ru) 2000-09-10
ES2139824T3 (es) 2000-02-16
EE9500076A (et) 1996-06-17
FI956016A (fi) 1996-06-17
NO955103D0 (no) 1995-12-15
EP0717043A1 (de) 1996-06-19
GR3032394T3 (en) 2000-05-31
IL116386A (en) 1999-06-20
HUT74166A (en) 1996-11-28
US5990121A (en) 1999-11-23
ATE186536T1 (de) 1999-11-15
CN1059442C (zh) 2000-12-13
PL180439B1 (pl) 2001-02-28
HU9503597D0 (en) 1996-02-28
PL311843A1 (en) 1996-06-24
AU709760B2 (en) 1999-09-09
AU4029495A (en) 1996-06-27
NZ280661A (en) 1997-06-24
EP0924211A2 (de) 1999-06-23
US6147087A (en) 2000-11-14
CN1133841A (zh) 1996-10-23
DE4444860A1 (de) 1996-06-20
KR960022517A (ko) 1996-07-18
ZA9510695B (en) 1996-07-03
FI956016A0 (fi) 1995-12-14
DK0717043T3 (da) 2000-05-08
NO955103L (no) 1996-06-17
MX9505097A (es) 1997-01-31
DE59507220D1 (de) 1999-12-16

Similar Documents

Publication Publication Date Title
AU3317495A (en) Aroyl-piperidine derivatives
ES2112029T3 (es) Nuevos filtros solares, composiciones cosmeticas fotoprotectoras que los contienen y utilizaciones.
GR3032394T3 (en) Use of 1,2-bridged 1,4-dihydropyridines as selective potassium channel modulators
HU9600914D0 (en) 4-indolylpiperazinyl derivatives
AU4585096A (en) New tricyclic derivatives, their preparation, their use for the preparation of optically active or racemic colchicine and thiocolchicine and analogues or derivatives and intermediates
NO972943D0 (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse
CA2220536A1 (fr) Nouveaux derives de filtres silicies sur leur partie aromatique, compositions cosmetiques photoprotectrices les contenant et utilisations
AU6193196A (en) Substituted 4H-pyrans
ATE229513T1 (de) Disubstituierte trans-3,4,4a,5,6,10b-hexahydro-2h-napht(1,2-b)- ,4-oxazine, verfahren zu deren herstellung und diese enthaltende pharmazeutigsche zusammensetzungen
DE69837628D1 (de) Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
ATE199897T1 (de) Aminierte 6,7,8,9-tetrahydro- cyclopenta(a)naphthalen- und 2,3-dihydro- cyclopenta(e)inden-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ES2059928T3 (es) Ciclopropanotiocarboxiamidas.
NO972942L (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse
ATE148462T1 (de) Isoxazole derivate als lichtschutzmittel
HUP9903423A3 (en) 3-descladinose-2,3-anhydroerythromycin derivatives